Show simple item record

dc.contributor.authorJimenez-Sousa, Maria Angeles 
dc.contributor.authorMedrano, Luz Maria 
dc.contributor.authorLiu, Pilar
dc.contributor.authorFernandez-Rodriguez, Amanda 
dc.contributor.authorAlmansa, Raquel
dc.contributor.authorGómez-Sánchez, Esther
dc.contributor.authorOrtega, Alicia
dc.contributor.authorHeredia-Rodríguez, María
dc.contributor.authorGómez-Pesquera, Estefanía
dc.contributor.authorTamayo, Eduardo
dc.contributor.authorResino, Salvador 
dc.date.accessioned2019-04-15T11:35:34Z
dc.date.available2019-04-15T11:35:34Z
dc.date.issued2017-12
dc.identifier.citationAnn Intensive Care. 2017 Dec;7(1):22.es_ES
dc.identifier.issn2110-5820es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7461
dc.description.abstractBACKGROUND: Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, being the primary cause of death from infection, especially if not recognized and treated promptly. The aim of this study was to analyze whether IL-6 rs1800795 polymorphism is associated with septic shock-related death in European white patients who underwent major surgery. METHODS: We performed a retrospective study on 202 septic shock patients who underwent major cardiac or abdominal surgery. The septic shock was established according to the international septic shock definition. The primary outcome variable was the death within 90 days after diagnosis of septic shock. The IL-6 rs1800795 polymorphism was genotyped by Sequenom's MassARRAY platform. RESULTS: The median age of the patients was 73 years, 63.4% were male, and more than 40% of patients had heart disease and hypertension. Overall, the survival analysis showed that 111 (55%) patients died with a survival median of 39 days (95% CI 30.7; 47.2). The genetic analysis association with survival was performed under a recessive genetic model (CC vs. GG/CG). Patients with IL-6 rs1800795 CC genotype had higher mortality rate than the IL-6 rs1800795 GG/CG genotype at days 7 [31.6% (6/19) vs. 10.4% (19/183); log-rank test (p = 0.005)] and 28 [57.9% (11/19) vs. 33.3% (61/183); log-rank test (p = 0.009)], and 90 [68.4% (13/19) vs. 53.5% (98/183); log-rank test (p = 0.006)]. The IL-6 rs1800795 CC genotype was associated with higher risk of septic shock-related death during the first 7 days [adjusted hazard ratio (aHR 4.65; p = 0.002), 28 days (aHR 2.50; p = 0.006), and 90 days (aHR 2.28; p = 0.006)] with septic shock. When patients were stratified by type of surgery, those with IL-6 rs1800795 CC genotype who underwent cardiac surgery had higher risk of death during the first 7 days (aHR 18.39; p = 0.001) and 28 days (aHR 6.1; p = 0.025) than IL-6 rs1800795 GG/GC carrier, whereas patients with IL-6 rs1800795 CC genotype who underwent abdominal surgery had higher risk of death during all follow-up (aHR 1.98; p = 0.050) than IL-6 rs1800795 GG/GC carrier. CONCLUSIONS: The presence of IL-6 rs1800795 CC genotype was associated with higher risk of septic shock-related death in patients who underwent major cardiac or abdominal surgery. These findings need robust validation in bigger independent cohorts.es_ES
dc.language.isoenges_ES
dc.publisherSpringer es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subjectIL-6es_ES
dc.subjectMajor surgeryes_ES
dc.subjectSNPses_ES
dc.subjectSeptic shockes_ES
dc.subjectSurvivales_ES
dc.titleIL-6 rs1800795 polymorphism is associated with septic shock-related death in patients who underwent major surgery: a preliminary retrospective studyes_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID28247301es_ES
dc.format.volume7es_ES
dc.format.number1es_ES
dc.format.page22es_ES
dc.identifier.doi10.1186/s13613-017-0247-8es_ES
dc.contributor.funderInstituto de Salud Carlos III 
dc.contributor.funderJunta de Castilla y León (España) 
dc.contributor.funderFundación Pfizer 
dc.description.peerreviewedes_ES
dc.relation.publisherversionhttps://doi.org/10.1186/s13613-017-0247-8es_ES
dc.identifier.journalAnnals of intensive carees_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-CompartirIgual 4.0 Internacional
This item is licensed under a: Atribución-NoComercial-CompartirIgual 4.0 Internacional